Stay updated on Atezolizumab With Bevacizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab With Bevacizumab in Solid Tumors Clinical Trial page.

Latest updates to the Atezolizumab With Bevacizumab in Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe record describes a completed Phase 1 study of atezolizumab in combination with bevacizumab and other treatments for solid tumors, with details on participant eligibility, treatment arms, and measured outcomes.SummaryDifference93%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check56 days agoChange DetectedAn access-denied 403 page is now shown, replacing the study details with a standard error screen and basic navigation. The detailed trial content is currently unavailable due to the error.SummaryDifference22%

Stay in the know with updates to Atezolizumab With Bevacizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab With Bevacizumab in Solid Tumors Clinical Trial page.